Centrient
Sustainable leader in antibiotics, statins and anti-fungals
Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs).
First established in 1869, our story has since been one of constant evolution and innovation. Today, we are a company 2,700-people strong with operations on four continents.
More than this, we are a pharmaceutical company with a clear mission: to improve lives by being at the centre of sustainable and accessible healthcare.
Our company has a common focus that unites each of us in our mission: across our global operations, we are committed to ensuring Quality, Reliability and Sustainability to customers, partners, patients and the world at large.
Moving forward, our vision is to be the leading, diversified and fully integrated partner to generics marketers.
Latest news
Planet B.io is a busy community, we are constantly developing and so are our collaborators, residents and members. To keep everyone updated we write articles and organise events. Take a look!
Planet B.io welcomes Thijs van Daal as Sales & Marketing associate
Since this week, Thijs van Daal has joined the team of Planet B.io as Sales & Marketing Associate.
Meet the newest Planet B.io residents
Over the past few months, the Planet B.io community on the Biotech Campus Delft welcomed several new members who each bring unique expertise to our ecosystem - ranging from high-containment bioprocessing technologies to circular biomaterials and plastic-free disposables. Meet Roylinx, Hecht Technology and Plastilose
From Sound to Scale | Hypesound innovates in Planet B.io’s Flexible Bio Lab
How can sound waves make microorganisms grow faster? In this interview, Hypesound CSO Ilia Vialshin, he explains how optimized sound stimulation can accelerate algae, yeast, and bacterial growth, without chemicals or major energy input, and why Planet B.io’s Flexible Bio Lab was the crucial missing link to move from theory to proof of concept.